On 14 October 2016, orphan designation (EU/3/16/1744) was granted by the European Commission to BrainRepair UG (haftungsbeschränkt), Germany, for autologous mononuclear cells derived from human cord blood for the treatment of periventricular leukomalacia.
Autologous mononuclear cells derived from human cord blood
|Disease / condition||
Treatment of periventricular leukomalacia
|Date of decision||
|Orphan decision number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
- Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;
- European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.